"He's in and out of consciousness, in incredible pain. ... He could pass any ... According to the ALS Association, Amyotrophic lateral sclerosis is a fatal condition that causes progressive ...

The UMass Chan Medical School in Worcester announced Thursday it received a $35 million gift that aims to advance research to ...

Henry Gosebruch, Neumora’s CEO since 2023, will depart. Elsewhere, Biogen dropped two antisense drugs in a pipeline cull and Voyager hit a setback for its ALS gene therapy.

USAISR is working with MIT Lincoln Lab to develop a new device for providing regional pain control in trauma patients at or ...

It works by switching off nociceptors in the peripheral nervous system, and therefore preventing pain signals getting to the ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Fifteen U.S. nonprofit organizations formed a new ALS group, ALS United, to help address the needs of people living with ALS.

The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other ...

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

Scientists Discover New Receptor for Nerve Growth Factor--a Promising Target for Treating Pain Dec. 5, 2024 — Researchers have found a new receptor for nerve growth factor that plays an ...

There is no escape from mental pain. It's necessary to learn techniques that soften the body's physiologic response to threats.

A global research collaboration has revealed how certain gut cells switch on pain signals, which can linger long after the ...